OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Stakeholders work to meet deadlines, maximize benefits, and close gaps.
Controlling conditions and preventing contamination are crucial for cell growth.
An effective data structure and communication are essential for delivering secure traceability.
October 08, 2021
Pfizer may pay up to $630 million for access to Voyager’s novel AAV capsids in transgene research.
Moderna’s new facility is expected to produce 500 million vaccine doses per year.
October 07, 2021
The $3 million investment will go towards various projects investigating key product attributes for therapeutic proteins.
October 06, 2021
New excipients for protein-based drug products reduce viscosity while maintaining protein stability.
October 04, 2021
Thermo Fisher’s new Swiss facility will initially produce CSL Limited’s recombinant factor IX product Idelvion.
October 03, 2021
Conventional and robotic automation inside closed systems reduces risk.
Evolving equipment designs meet the unique needs of continuous processing techniques.
Part 1 of this article series demonstrates, using real-world process data, that the four fundamental assumptions underlying the classical Shewhart control charts—randomness, independence, constant average, and constant variation—are often not met.
September 30, 2021
The new LabVantage Enterprise SaaS adds full configurability and custom interfacing capabilities.
NewAge Industries has completed a plant expansion that added new cleanrooms to its headquarters in Southampton, Pa.